Feb 24, 2021
United Therapeutics Corporation Reports Fourth Quarter And Full Year 2020 Financial Results
Feb 10, 2021
United Therapeutics Announces Commercial Launch Of The Remunity® Pump For Remodulin®
Jan 13, 2021
United Therapeutics Announces New England Journal of Medicine Publication of the INCREASE Study Evaluating Tyvaso® in Pulmonary Hypertension Associated with Interstitial Lung Disease
Dec 28, 2020
United Therapeutics Announces Agreement To Acquire Priority Review Voucher
Dec 09, 2020
United Therapeutics Receives FDA Orphan Drug Designation For Treprostinil For The Treatment Of Idiopathic Pulmonary Fibrosis
Nov 24, 2020
United Therapeutics Releases Its First Corporate Responsibility Report
Oct 28, 2020
United Therapeutics Corporation Reports Third Quarter 2020 Financial Results
Oct 22, 2020
United Therapeutics Highlights Poster Presentations from the Recent CHEST 2020 Meeting
Oct 21, 2020
United Therapeutics Corporation To Report Third Quarter 2020 Financial Results Before The Market Opens On Wednesday, October 28, 2020
Oct 15, 2020
United Therapeutics to Present New Tyvaso® Clinical and Treprostinil Real-World Data at CHEST Annual Meeting 2020
Sep 21, 2020
CollPlant and United Therapeutics Announce Exercise of Option that will Expand their Collaboration to Include 3D Bioprinting of Human Kidneys for Transplant
Sep 16, 2020
United Therapeutics Corporation to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Sep 11, 2020
United Therapeutics Corporation Appoints Linda Maxwell to Its Board of Directors
Aug 05, 2020
United Therapeutics Corporation to Present at the Wedbush PacGrow Healthcare Virtual Conference
Jul 29, 2020
United Therapeutics Corporation Reports Second Quarter 2020 Financial Results
Jun 17, 2020
United Therapeutics Announces Increase Data Presentation at an American Thoracic Society Virtual Session
Jun 05, 2020
United Therapeutics Corporation Files Lawsuit Against Liquidia For Infringement Of Tyvaso Patents
May 06, 2020
United Therapeutics Corporation To Present At The BofA Securities Virtual Health Care Conference 2020
Apr 29, 2020
United Therapeutics Corporation Reports First Quarter 2020 Financial Results
Apr 23, 2020
United Therapeutics Announces Additional Results From FREEDOM-EV Study Showing The Hemodynamic And Risk Status Reduction Benefits Of Orenitram Treatment In Patients With Pulmonary Arterial Hypertension